PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsDermatitis herpetiformis
MeSH D003874 - dermatitis herpetiformis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003872:Dermatitis
55 Companies
27 Drugs
$
Success rate
D012872:Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D001327:Autoimmune diseases
1 Company
1 Drug
$
Success rate
D003874: 
Dermatitis herpetiformis
131 Companies
19 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieDapsone Aczone  2005-07-07   
Alembic PharmaceuticalsDapsone Dapsone  2023-10-27   
AllerganDapsone Dapsone  2017-03-23   
AlmirallDapsone Aczone 2033-11-18 2016-02-24   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
9/9
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Methylprednisolone
AbbVie
Dexamethasone,
Prednisolone,
Prednisolone tebutate,
Triamcinolone,
Triamcinolone acetonide,
Triamcinolone hexacetonide
Alcon Research
Dexamethasone,
Prednisolone,
Prednisolone tebutate
Allergan
Cortisone,
Cortisone acetate,
Dapsone,
Dexamethasone,
Methylprednisolone,
Prednisolone,
Prednisolone tebutate,
Triamcinolone,
Triamcinolone acetonide,
Triamcinolone hexacetonide
Almirall
Dapsone
Apotex
Dexamethasone,
Triamcinolone,
Triamcinolone acetonide,
Triamcinolone hexacetonide
1
2
3
4
5
6
...
9
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use